N-Formylmethionyl-Leucylphenylalanine

N-Formylmethionyl-Leucylphenylalanine

SCHEMBL39529

CSCC[C@H](NC=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
FPR1 P21462 4/20 0.61
FPR2 P25090 4/20 0.61
LTA4H P09960 1/20 0.53
MME P08473 2/20 0.52
MMP2 P08253 1/20 0.50
MMP7 P09237 1/20 0.50
MMP9 P14780 1/20 0.50
MMP12 P39900 1/20 0.50
MMP13 P45452 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
N-Formylmethionyl-Leucylphenylalanine SCHEMBL4592799 1.00 FPR1 (0.61) FPR1FPR2LTA4HMMEMMP2
N-Formylmethionyl-Leucylphenylalanine SCHEMBL17202476 1.00 FPR1 (0.61) FPR1FPR2LTA4HMMEMMP2
N-Formylmethionyl-Leucylphenylalanine SCHEMBL39528 1.00 FPR1 (0.61) FPR1FPR2LTA4HMMEMMP2
N-Formylmethionyl-Leucylphenylalanine SCHEMBL4969844 1.00 FPR1 (0.61) FPR1FPR2LTA4HMMEMMP2
N-Formylmethionyl-Leucylphenylalanine SCHEMBL9903983 1.00 FPR1 (0.61) FPR1FPR2LTA4HMMEMMP2
N-Formylmethionyl-Leucylphenylalanine SCHEMBL7127847 1.00 FPR1 (0.61) FPR1FPR2LTA4HMMEMMP2
SCHEMBL27066372 0.99 FPR1 (0.60) FPR1FPR2LTA4HMMEMMP2
SCHEMBL2413701 0.99 FPR1 (0.60) FPR1FPR2LTA4HMMEMMP2
SCHEMBL27066369 0.94 FPR1 (0.56) FPR1FPR2
SCHEMBL27066397 0.94 FPR1 (0.56) FPR1FPR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 4128 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4735882-A1 BAT-BASED METHOD FOR DETERMINING THE PREVALENCE AND/OR SEVERITY OF AN ALLERGY IN AN INDIVIDUAL AND KITS THEREFORE Forschungszentrum Borstel, Leibniz Lungenzentrum (DE) 2026-05-06 EP claimed
WO-2025262329-A1 SYNTHETIC MOLECULES COMPRISING TLR2 LIGANDS SYNTAB THERAPEUTICS GMBH (DE) 2025-12-26 WO claimed
US-12492367-B2 Sensor chip capable of culturing cells and of analyzing cell-derived substance, and cell activity quantitative analysis method using the same AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) 2025-12-09 US claimed
US-12442748-B1 Stimulus response testing using automated flow cytometry protocols SHERO DIAGNOSTICS (US) 2025-10-14 US claimed
US-20250243445-A1 BIOSENSING CHIP TO ANALYZE CELL-DERIVED MATERIALS DURING CELL CULTURE, AND METHOD FOR QUANTITATIVE ANALYSIS OF CELL ACTIVITY USING THE SAME AJOU UNIVERSITY INDUSTRY-ACDEMIC COOPERATION FOUNDATION (KR) 2025-07-31 US claimed
CN-119296094-B Contour feature enhancement-based arbitrary shape scene text detection method 天津大学 2025-05-30 CN claimed
CN-120069530-A Building overhead operation risk prediction method 无锡云智翼创新智能科技有限公司 2025-05-30 CN claimed
CN-120014453-A Multi-source remote sensing image classification method based on layered multi-mode feature aggregation and axial transducer 湖州师范学院 2025-05-16 CN claimed
US-20250157661-A1 MONITORING INFLAMMATION STATUS MOLOGIC LIMITED (GB) 2025-05-15 US claimed
WO-2025093747-A1 NOVEL RAPID HIGH-THROUGHPUT METHOD OF NETOSIS INDUCTION AND INHIBITION WITH PHYSIOLOGICALLY RELEVANT MOLECULES BELGIAN VOLITION SRL (BE) 2025-05-08 WO claimed
EP-0345906-B1 Unique elastase induced fibrinogen cleavage site antigens MERCK & CO INC (US) 1996-03-13 EP claimed
EP-0438497-B1 VASOPERMEABILITY-ENHANCING CONJUGATES UNIV SOUTHERN CALIFORNIA (US) 1996-03-13 EP claimed
US-5459057-A Treatment with sphignosine or its analog EMORY UNIVERSITY (US) 1995-10-17 US claimed
EP-0519976-A4 NEUTROPHIL STIMULATING PEPTIDES 1993-06-09 EP claimed
EP-0519976-A1 NEUTROPHIL STIMULATING PEPTIDES. PEPTIDE TECHNOLOGY LTD (AU) 1992-12-30 EP claimed
WO-1991013908-A1 NEUTROPHIL STIMULATING PEPTIDES PEPTIDE TECHNOLOGY LTD. (AU) 1991-09-19 WO claimed
WO-1990007571-A1 METHOD OF MODIFYING CELLULAR DIFFERENTIATION AND FUNCTION AND COMPOSITIONS THEREFOR EMORY UNIVERSITY (US) 1990-07-12 WO claimed
US-4916118-A PHOSPHOLIPIDS IN LIPOSOME FORM ; ANTICARCINOGENIC AGENTS, ANTITUMOR AGENTS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1990-04-10 US claimed
EP-0345906-A2 Unique elastase induced fibrinogen cleavage site antigens MERCK & CO. INC. (US) 1989-12-13 EP claimed
EP-0256989-A1 Pharmaceutical administration systems containing chemotactic peptides BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1988-02-24 EP claimed